Genetic Technologies Executes Settlement and License Agreement with GeneSeek Inc.
May 9, 2012
In compliance with ASX Continuing Disclosure Rules, Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to report that it has executed a Settlement and License Agreement with GeneSeek Inc. (“GeneSeek”) of Lincoln, Nebraska, USA (see: https://www.neogen.com/geneseek/). Under the terms of the Agreement, GeneSeek is granted certain non-exclusive rights to a number of GTG patents [...]
Implant Sciences Appoints Dr. Darryl Jones as VP of Sales and Marketing
May 9, 2012
WILMINGTON, MA, --Continuing its record of attracting top industry talent, Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the appointment of Dr. Darryl Jones as Vice President of Sales and Marketing. Dr. Jones has led significant sales growth at some [...]
May 9, 2012
WALTHAM, Mass. – PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, introduced the Supra-dTM QuEChERS Dispersive Solid Phase Extraction (SPE) solution for sample preparation using the QuEChERS method (Quick, Easy, Cheap, Effective, Rugged, Safe). This method, the most widely used approach in pesticide residue analysis, helps [...]
Spectris appoints new non-executive director
May 9, 2012
Spectris today announces that Martha B. Wyrsch will join the Board as a non-executive director with effect from 1 June 2012. Martha is currently President of Vestas Americas, a position she has held since June 2009. Vestas Americas is a subsidiary of Vestas Wind Systems A/S, which is listed on the NASDAQ OMX in Denmark. [...]
Courtagen Submits Pre-IDE Information Package for the Avantra® Q400 Workstation and QPDx® BioChip
May 9, 2012
WOBURN, Mass.,-- Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced that the company has submitted its first pre- IDE (Investigational Device Exemption) information package to the U.S. Food and Drug Administration for the Company’s Avantra® Q400 BioMarker [...]
May 9, 2012
Bournemouth, UK –Solentim, the provider of high resolution imaging for fast clone selection, has introduced the new Cell Metric™ CLD bench top system, optimised to provide fast, reliable and automated cell line development (CLD). The high resolution offered by Cell Metric’s unique cell imaging and analysis system offers an alternative approach to manually checking cell [...]
May 9, 2012
Charlottesville, VA – ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and RNA, today announced that it has entered into an agreement with Quanta BioSciences to incorporate ZyGEM’s advanced enzymatic RNA extraction technology into Quanta’s leading reagents for quantitative PCR sold to customers worldwide. The collaboration will enable [...]
May 9, 2012
SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it has signed an agreement with U.S. health insurance provider Coventry Health Care National Network to provide coverage for the Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 PLUS laboratory-developed test (LDT). The test detects certain [...]
Microsaic Signs Commercial Agreement with International Partner
May 9, 2012
Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, is pleased to announce the signing of a significant agreement to provide its miniature mass spectrometer - the Microsaic MiD - as an Original Equipment Manufacturer (OEM) to an international supplier of laboratory equipment. Under the terms of the agreement, the new supplier will [...]
Whole Genome Sequencing in Type 2 Diabetes Genetic Study
May 9, 2012
MOUNTAIN VIEW, Calif.– Complete Genomics Inc. (NASDAQ: GNOM) announced today that it has sequenced the genomes of 600 individuals from 20 Mexican-American families from San Antonio in what is thought to be the largest whole genome sequencing family study conducted to date and the first such study of its kind in a Latino population. “We [...]
